Literature DB >> 20554826

Evaluation of colorimetric methods using nicotinamide for rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis.

Niuris C Mirabal1, Sergio L Yzquierdo, Dihadenys Lemus, Mariela Madruga, Yoslaine Milián, Miguel Echemendía, Howard Takiff, Anandi Martin, Patrick Van der Stuyf, Juan Carlos Palomino, Ernesto Montoro.   

Abstract

The direct detection of pyrazinamide resistance in Mycobacterium tuberculosis is sufficiently difficult that many laboratories do not attempt it. Most pyrazinamide resistance is caused by mutations that inactivate the pyrazinamidase enzyme needed to convert the prodrug pyrazinamide to its active form. We evaluated two newer and simpler methods to assess pyrazinamidase activity, the nitrate reductase and malachite green microtube assays, using nicotinamide in place of pyrazinamide. A total of 102 strains were tested by these methods and the results compared with those obtained by the classic Wayne assay. Mutations in the pncA gene were identified by sequencing the pncA genes from all isolates in which pyrazinamide resistance was detected by any of the three methods. Both the nitrate reductase and malachite green microtube assays showed sensitivities of 93.75% and specificities of 97.67%. Mutations in the pncA gene were found in 14 of 16 strains that were pyrazinamide resistant and in 1 of 4 strains that were sensitive by the Wayne assay. Both of these simple methods, used with nicotinamide, are promising and inexpensive alternatives for the rapid detection of pyrazinamide resistance in limited-resource countries.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554826      PMCID: PMC2916567          DOI: 10.1128/JCM.00311-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  36 in total

1.  Multicenter evaluation of the nitrate reductase assay for drug resistance detection of Mycobacterium tuberculosis.

Authors:  Anandi Martin; Ernesto Montoro; Dihadenys Lemus; Norberto Simboli; Nora Morcillo; Maritza Velasco; José Chauca; Lucía Barrera; Viviana Ritacco; Françoise Portaels; Juan Carlos Palomino
Journal:  J Microbiol Methods       Date:  2005-11       Impact factor: 2.363

2.  The effect of nicotinic acid amide on experimental tuberculosis of white mice.

Authors:  D McKENZIE; L MALONE
Journal:  J Lab Clin Med       Date:  1948-10

3.  Activation of pyrazinamide and nicotinamide in acidic environments in vitro.

Authors:  W McDERMOTT; R TOMPSETT
Journal:  Am Rev Tuberc       Date:  1954-10

4.  Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay.

Authors:  K A Kristian Angeby; Lisbeth Klintz; Sven E Hoffner
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

5.  A simple way of detecting pyrazinamide resistance.

Authors:  E Brander
Journal:  Tubercle       Date:  1972-06

6.  Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide.

Authors:  Y Zhang; A Scorpio; H Nikaido; Z Sun
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

7.  Simple pyrazinamidase and urease tests for routine identification of mycobacteria.

Authors:  L G Wayne
Journal:  Am Rev Respir Dis       Date:  1974-01

8.  Comparative evaluation of Löwenstein-Jensen proportion method, BacT/ALERT 3D system, and enzymatic pyrazinamidase assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosis.

Authors:  Pushpendra Singh; Clement Wesley; G P S Jadaun; Sunil Kumar Malonia; R Das; P Upadhyay; J Faujdar; P Sharma; P Gupta; Abhay Kumar Mishra; Kalpana Singh; D S Chauhan; V D Sharma; U D Gupta; K Venkatesan; V M Katoch
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

9.  Nitrate reductase assay for the rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide.

Authors:  Anandi Martin; Andrés Cubillos-Ruiz; Andrea Von Groll; Patricia Del Portillo; Françoise Portaels; Juan Carlos Palomino
Journal:  J Antimicrob Chemother       Date:  2007-11-01       Impact factor: 5.790

10.  Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.

Authors:  K W Lee; J M Lee; K S Jung
Journal:  J Korean Med Sci       Date:  2001-10       Impact factor: 2.153

View more
  7 in total

1.  Role of pncA and rpsA gene sequencing in detection of pyrazinamide resistance in Mycobacterium tuberculosis isolates from southern China.

Authors:  Yaoju Tan; Zuqiong Hu; Tianyu Zhang; Xingshan Cai; Haobin Kuang; Yanwen Liu; Junyu Chen; Feng Yang; Ke Zhang; Shouyong Tan; Yanlin Zhao
Journal:  J Clin Microbiol       Date:  2013-10-16       Impact factor: 5.948

2.  Rapid detection of multidrug-resistant Mycobacterium tuberculosis using the malachite green decolourisation assay.

Authors:  Ahmet Yilmaz Coban; Meltem Uzun
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-12       Impact factor: 2.743

3.  Mutations in fbiD (Rv2983) as a Novel Determinant of Resistance to Pretomanid and Delamanid in Mycobacterium tuberculosis.

Authors:  Dalin Rifat; Si-Yang Li; Thomas Ioerger; Keshav Shah; Jean-Philippe Lanoix; Jin Lee; Ghader Bashiri; James Sacchettini; Eric Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

4.  Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Korea and analysis of the correlation between the mutations and pyrazinamidase activity.

Authors:  Jee-Hyun Yoon; Ji-Sun Nam; Kyung-Jin Kim; Young-Tae Ro
Journal:  World J Microbiol Biotechnol       Date:  2014-07-18       Impact factor: 3.312

Review 5.  'Z(S)-MDR-TB' versus 'Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility.

Authors:  Ying Zhang; Kwok Chiu Chang; Chi-Chiu Leung; Wing Wai Yew; Brigitte Gicquel; Dorothy Fallows; Gilla Kaplan; Richard E Chaisson; Wenhong Zhang
Journal:  Emerg Microbes Infect       Date:  2012-07-25       Impact factor: 7.163

6.  Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study.

Authors:  Paolo Miotto; Andrea M Cabibbe; Silke Feuerriegel; Nicola Casali; Francis Drobniewski; Yulia Rodionova; Daiva Bakonyte; Petras Stakenas; Edita Pimkina; Ewa Augustynowicz-Kopeć; Massimo Degano; Alessandro Ambrosi; Sven Hoffner; Mikael Mansjö; Jim Werngren; Sabine Rüsch-Gerdes; Stefan Niemann; Daniela M Cirillo
Journal:  mBio       Date:  2014-10-21       Impact factor: 7.867

Review 7.  A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis.

Authors:  Michael G Whitfield; Heidi M Soeters; Robin M Warren; Talita York; Samantha L Sampson; Elizabeth M Streicher; Paul D van Helden; Annelies van Rie
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.